Who is sponsoring NCT01982006?

NCT01982006 is sponsored by University Hospital, Bordeaux.

What drugs are being tested in NCT01982006?

Interventions in NCT01982006: Cataract surgery with Phacoemulsification, Femtosecond laser-assisted cataract surgery.

Is NCT01982006 still recruiting?

NCT01982006 is currently completed. Last updated 4 October 2018.

Last reviewed 2018-10-04 · How we verify

NCT01982006: FEMCAT

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Economic Evaluation of Femtosecond Laser Assisted Cataract Surgery

Completed Phase 3 Last updated 4 October 2018

What this trial tests

Phase 3 trial testing Cataract surgery with Phacoemulsification in Cataract in 920 participants. Completed in 15 December 2016.

Timeline

9 October 2013

Primary endpoint
15 December 2016

15 December 2016

Quick facts

Lead sponsor	University Hospital, Bordeaux
Phase	Phase 3
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	920
Start date	9 October 2013
Primary completion	15 December 2016
Estimated completion	15 December 2016
Sites	5 locations across France

Drugs / interventions tested

Cataract surgery with Phacoemulsification
Femtosecond laser-assisted cataract surgery

Conditions studied

Cataract — all drugs for Cataract →

Sponsor

University Hospital, Bordeaux

Who can join

22 and older, any sex, with Cataract. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Cataract is the leading cause of blindness worldwide and cataract surgery is the most frequent surgery performed in France. A new technology, the femtosecond laser-assisted cataract surgery, has to be compared with phacoemulsification alone, the conventional cataract surgery, to determine the economic impact of femtosecond laser-assisted process for the French healthcare insurance.

Publications & conference data

4 peer-reviewed publications reference this trial (live from Europe PMC):

Femtosecond laser-assisted versus phacoemulsification cataract surgery (FEMCAT): a multicentre participant-masked randomised superiority and cost-effectiveness trial.
Schweitzer C, Brezin A, Cochener B, Monnet D, et al · · 2020 · cited 80× · PMID 31954466 · DOI 10.1016/s0140-6736(19)32481-x
Laser-assisted cataract surgery versus standard ultrasound phacoemulsification cataract surgery.
Day AC, Gore DM, Bunce C, Evans JR. · · 2016 · cited 74× · PMID 27387849 · DOI 10.1002/14651858.cd010735.pub2
Cost Utility and Value of Information Analysis of Femtosecond Laser-Assisted Cataract Surgery.
Bénard A, Sitta R, Brezin AP, Cochener B, et al · · 2023 · cited 12× · PMID 37200037 · DOI 10.1001/jamaophthalmol.2023.1716
A new approach for sample size calculation in cost-effectiveness studies based on value of information.
Bader C, Cossin S, Maillard A, Bénard A. · · 2018 · cited 10× · PMID 30348087 · DOI 10.1186/s12874-018-0571-1

Verify or expand the search:

Other recruiting trials for Cataract

Currently open trials in the same condition.

NCT07301385 — Evaluation of Head-Mounted Spatial Computing and Three-Dimensional (3D) Visualization in Ocular Microsurgery: A Safety a · NA · recruiting
NCT07462000 — Aqueous Humor and Ocular Tissue Analysis in Glaucoma and Cataract · NA · recruiting
NCT06891092 — Vivinex Impress XY1-EM vs RayOne EMV · NA · recruiting
NCT07218796 — Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compar · Phase 3 · recruiting
NCT07218783 — Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compar · Phase 3 · recruiting

Other University Hospital, Bordeaux trials

Trials by the same sponsor.

NCT07506928 — NEURO - Prognostication Using Late Somatosensory Evoked - Potentials · NA · not yet recruiting
NCT07524036 — Impact of a Nursing Educational Consultation on the Patient's Adherence to Their Post-stroke Care Plan. · NA · not yet recruiting
NCT07527494 — Digital MEDIcal TWIN for the Prediction of Arrhythmic Sudden Cardiac Death After a Myocardial Infarction · NA · not yet recruiting
NCT07527442 — Efficacy and Safety of Circumcision Alone on Risk of Febrile Urinary Tract Infections in Boys With Posterior Urethral Va · Phase 2 · not yet recruiting
NCT07478523 — FAPI-PET Value for the Initial Screening of Pancreatic and Biliary Cancers · Phase 2 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT01982006 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital, Bordeaux
Last refreshed: 4 October 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01982006.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing